Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00764985Completed

Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis

Role: collaborator

NCT00719277Not ApplicableUnknown

Feasibility Study: Sleuth Monitoring System

Role: lead

NCT00861133Not ApplicableUnknown

Cryptogenic Stroke Study

Role: lead

NCT00717106Unknown

Observational Study of the Sleuth Implantable ECG Monitoring System

Role: lead

NCT00517023Not ApplicableUnknown

Eastbourne Syncope Assessment Study II

Role: collaborator

All 5 trials loaded